Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.
about
Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition.Effects of rifampin and ketoconazole on the pharmacokinetics of nilotinib in healthy participants.Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction
P2860
Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacokinetics of ruboxistau ...... cin-mediated CYP3A4 induction.
@ast
Pharmacokinetics of ruboxistau ...... cin-mediated CYP3A4 induction.
@en
type
label
Pharmacokinetics of ruboxistau ...... cin-mediated CYP3A4 induction.
@ast
Pharmacokinetics of ruboxistau ...... cin-mediated CYP3A4 induction.
@en
prefLabel
Pharmacokinetics of ruboxistau ...... cin-mediated CYP3A4 induction.
@ast
Pharmacokinetics of ruboxistau ...... cin-mediated CYP3A4 induction.
@en
P2093
P2860
P1476
Pharmacokinetics of ruboxistau ...... cin-mediated CYP3A4 induction.
@en
P2093
James R Voelker
Jennifer L Burkey
Kwee Poo Yeo
Ming Tung Lim
Stephen D Wise
Stephen L Lowe
P2860
P304
P356
10.1111/J.1365-2125.2005.02540.X
P407
P577
2006-02-01T00:00:00Z